Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | PIM1 | P11309 | 1/20 | 0.32 |
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.31 |
| ▸ | UTRN | P46939 | 1/20 | 0.31 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.30 |
| ▸ | MET | P08581 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24118957 | 0.97 | ALDH1A1 (0.34) | TDP1L3MBTL1CYP1A1CYP1B1PIM1 | |
| SCHEMBL23740552 | 0.96 | ALDH1A1 (0.33) | TDP1L3MBTL1CYP1A1CYP1B1PIM1 | |
| SCHEMBL23740731 | 0.95 | TDP1 (0.32) | TDP1L3MBTL1CYP1A1CYP1B1PIM1 | |
| SCHEMBL23740474 | 0.93 | ALDH1A1 (0.32) | TDP1L3MBTL1CYP1A1ALDH1A1MAPT | |
| SCHEMBL21863022 | 0.93 | TDP1 (0.34) | TDP1L3MBTL1CYP1A1ALDH1A1MAPT | |
| SCHEMBL21863150 | 0.93 | MAPT (0.36) | TDP1L3MBTL1CYP1A1ALDH1A1MAPT | |
| SCHEMBL23740481 | 0.93 | ALDH1A1 (0.32) | TDP1L3MBTL1ALDH1A1MAPT | |
| SCHEMBL23740478 | 0.92 | ALDH1A1 (0.32) | TDP1L3MBTL1CYP1A1ALDH1A1MAPT | |
| SCHEMBL24118979 | 0.92 | SIRT2 (0.33) | TDP1L3MBTL1CYP1A1PIM1PRKDC | |
| SCHEMBL21666766 | 0.92 | TUBB4A (0.34) | TDP1L3MBTL1CYP1A1CYP1B1PIM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210395263-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE | LT MATERIALS CO., LTD. (KR) | 2021-12-23 | — | — | US | disclosed |
| EP-3862353-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE | LT Materials Co., Ltd. (KR) | 2021-08-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210395263-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE | ODC1, AOX1, CYP1B1 | TDP1 1917/4885L3MBTL1 1479/4885CYP1A1 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.